GR3004281T3 - - Google Patents

Info

Publication number
GR3004281T3
GR3004281T3 GR910402220T GR910402220T GR3004281T3 GR 3004281 T3 GR3004281 T3 GR 3004281T3 GR 910402220 T GR910402220 T GR 910402220T GR 910402220 T GR910402220 T GR 910402220T GR 3004281 T3 GR3004281 T3 GR 3004281T3
Authority
GR
Greece
Prior art keywords
soporifics
pgds
tranquilizer
keto
dihydro
Prior art date
Application number
GR910402220T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3004281T3 publication Critical patent/GR3004281T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
GR910402220T 1987-01-28 1992-04-07 GR3004281T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1882187 1987-01-28

Publications (1)

Publication Number Publication Date
GR3004281T3 true GR3004281T3 (el) 1993-03-31

Family

ID=11982228

Family Applications (1)

Application Number Title Priority Date Filing Date
GR910402220T GR3004281T3 (el) 1987-01-28 1992-04-07

Country Status (8)

Country Link
US (3) US5073569A (el)
EP (1) EP0281239B1 (el)
KR (1) KR930006201B1 (el)
AT (1) ATE74126T1 (el)
CA (1) CA1322749C (el)
DE (1) DE3869444D1 (el)
ES (1) ES2032956T3 (el)
GR (1) GR3004281T3 (el)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212200A (en) * 1987-09-18 1993-05-18 R-Tech Ueno, Ltd. Ocular hypotensive agents
US6420422B1 (en) 1987-09-18 2002-07-16 Sucampo Pharmaceuticals, Inc. Ocular hypotensive agents
ATE108330T1 (de) * 1987-09-18 1994-07-15 R Tech Ueno Ltd Hypotensive okulare mittel.
JP2597629B2 (ja) 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
US5321128A (en) * 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
JP2721414B2 (ja) * 1988-09-06 1998-03-04 フアーマシア・アンド・アツプジヨン・アー・ベー 縁内障または眼圧亢進の治療のためのプロスタグランジン誘導体
US5296504A (en) * 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US6187813B1 (en) 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
ATE122563T1 (de) * 1989-07-27 1995-06-15 Ueno Seiyaku Oyo Kenkyujo Kk Verwendung von 15-keto-prostansäure-derivaten zur herstellung eines medikaments für die verbesserung der ausscheidung des kaliumions.
US5234954A (en) * 1989-07-27 1993-08-10 K.K. Ueno Seiyaku Oyo Kenkyujo Treatment of hyperlipidemia with 15-keto-prostaglandin compounds
ATE121624T1 (de) * 1989-08-09 1995-05-15 Ueno Seiyaku Oyo Kenkyujo Kk Verwendung von prostansäurederivaten zur herstellung von arzneimitteln zur verbesserung der ausscheidung von nichtprotein in die därme.
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
CA2030345C (en) * 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
US5254588A (en) * 1989-11-22 1993-10-19 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of pulmonary dysfunction with 15-ketoprostaglandin compounds
US5256696A (en) * 1989-11-22 1993-10-26 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of cardiac dysfunction with 15-ketoprostaglandin compounds
TW249226B (el) * 1990-04-04 1995-06-11 Aderk Ueno Kk
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
ATE141794T1 (de) * 1991-03-14 1996-09-15 R Tech Ueno Ltd Stimulierung von wundheilung mit 15-keto- prostaglandinverbindungen
DK1083168T3 (da) 1998-05-25 2003-12-15 Taisho Pharmaceutical Co Ltd Prostaglandinderivat
AR030275A1 (es) 2000-03-24 2003-08-20 Sucampo Pharmaceuticals Inc Composicion que inhibe la apoptosis y uso de un compuesto 15-ceto-prostaglandina- para producirla
DE60139002D1 (de) * 2000-04-06 2009-07-30 Sucampo Ag Gallensäurefördernde zusammensetzung für lebertransplantation welche ein 15-keto prostaglandin enthält
TWI302100B (en) 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
AU2002330747B2 (en) 2001-08-31 2007-07-19 Sucampo Ag Prostaglandin analogs as chloride channel opener
WO2005018646A1 (ja) 2003-08-21 2005-03-03 Sucampo Ag 眼科用組成物
ES2379652T3 (es) * 2002-10-23 2012-04-30 Sucampo Ag Compuestos de prostaglandina para el tratamiento de obesidad
CN1753680B (zh) 2002-12-27 2010-12-08 苏坎波公司 用于治疗腹部不适的前列腺素衍生物
WO2005002588A1 (en) * 2003-07-03 2005-01-13 Sucampo Ag Enteric coated composition comprising prostaglandin analogs as chloride channel opener
TWI495471B (zh) * 2003-08-12 2015-08-11 R Tech Ueno Ltd 促進毛髮生長之組成物及方法
US7321057B2 (en) * 2004-08-02 2008-01-22 R-Tech Ueno, Ltd. Method for manufacturing prostaglandin analogue
DK1841433T3 (da) 2005-01-27 2012-01-16 Sucampo Ag Præparat til behandling af lidelser i centralnervesystemet
ATE489955T1 (de) 2005-03-04 2010-12-15 Sucampo Ag Verfahren und zusammensetzung zur behandlung von peripheren gefässkrankheiten
US20060281818A1 (en) 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders
AU2006234632B2 (en) * 2005-04-12 2011-10-27 Sucampo Ag Combined use of prostaglandin compound and proton pump inhibitor for the treatment of gastrointestinal disorders
CA2637274C (en) 2006-01-24 2013-06-04 R-Tech Ueno, Ltd. Soft-gelatin capsule formulation
NZ570190A (en) * 2006-01-24 2011-03-31 Sucampo Ag Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
CN103768070A (zh) * 2006-03-13 2014-05-07 株式会社·R-技术上野 水性组合物
US8871752B2 (en) * 2008-02-19 2014-10-28 Sucampo Ag Method for modulating stem cell growth
US8609729B2 (en) 2009-04-15 2013-12-17 Sucampo Ag Method for treating macular degeneration
US8569279B2 (en) * 2009-05-27 2013-10-29 Sucampo Ag Method for modulating claudin mediated functions
US9084815B2 (en) * 2009-09-16 2015-07-21 Sucampo Ag Method for treating damage induced by an anti-tumor agent, treating mucositis and treating tumor
EP2694077A4 (en) 2011-04-07 2015-01-21 Sucampo Ag METHOD FOR TREATING ASTHENOPY
RU2648474C2 (ru) 2011-08-05 2018-03-26 Сукампо Аг Способ лечения шизофрении
AR092821A1 (es) 2012-04-20 2015-05-06 Sucampo Ag Conjugado de derivado de acido graso-polimero
US20150057351A1 (en) 2013-08-22 2015-02-26 Sucampo Ag Method for treating neuropathic pain
AR105029A1 (es) 2015-06-19 2017-08-30 Sucampo Ag Composición farmacéutica que comprende derivado de ácido graso

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1476661A (en) * 1974-05-13 1977-06-16 American Cyanamid Co Prostaglandins
ATE108330T1 (de) * 1987-09-18 1994-07-15 R Tech Ueno Ltd Hypotensive okulare mittel.

Also Published As

Publication number Publication date
ATE74126T1 (de) 1992-04-15
EP0281239A2 (en) 1988-09-07
ES2032956T3 (es) 1993-03-01
KR880008986A (ko) 1988-09-13
CA1322749C (en) 1993-10-05
KR930006201B1 (ko) 1993-07-08
US5137915A (en) 1992-08-11
US5073569A (en) 1991-12-17
EP0281239B1 (en) 1992-03-25
DE3869444D1 (de) 1992-04-30
US5534547A (en) 1996-07-09
EP0281239A3 (en) 1988-09-21

Similar Documents

Publication Publication Date Title
GR3004281T3 (el)
DE3853191D1 (de) Arzneimittelträger.
JPS6450858A (en) Manufacture of 2,2,6,6-tetramethyl-4- piperidylamine
DE3869007D1 (de) Oxydation von alkanen.
DE3886411D1 (de) Synthetisches gen.
EP0411733A3 (en) 11-beta-aryle-gona-4,9-dien-3-ones
ATE82257T1 (de) Antiarrythmische derivate 1.
GR3004959T3 (el)
IT8820935A0 (it) Procedimento per la preparazione di 1,2,5,6,9,10 esabromociclododecano.
FI881413A (fi) Foerfarande foer framstaellning av 3'-azido-3'-deoxitymidin.
AP8800109A0 (en) "Heterocyclic insecticides".
ZA88498B (en) Alkylmelatonins
EP0340391A3 (en) 1,4-disubstituted-2,3,4,6-tetrahydroxy-1,4-diphosphorinane and their oxides or sulfides
AU634003B2 (en) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
GR3017358T3 (en) 5-Aryl-3H-1,2,4-triazol-3-ones and their use as anticonvulsants.
EP0279633A3 (en) Anticonvulsant agents
JPS6440519A (en) Polyesters of 4,4-dihydroxydicyclohexyl
NO903338D0 (no) Fremgangsmaate for mikrobiologisk fremstilling av l-carnitin.
NO880409D0 (no) Fremgangsmaate for fremstilling av 14,15-substituerte lanosteroler.
MY104318A (en) Novel thiopen compounds and their preparation
IT8723266A0 (it) Procedimento per la fabbricazione di tappeti e simili.
LT2342B (lt) 2,6-dioksopiperazino gavimo budas
SU1269465A1 (ru) Способ получения 2-анилино-7-гидрокси-6н-1,3,4-тиадиазепинов
IE873477L (en) Preparation of 1,1,2,2-tetrahydroperfluoroalkanols and their¹esters.
FI870462A0 (fi) Foerfarande foer framstaellning av 4(5)-substituerade imidazolderivat.